文献速递肿瘤 PET/CT放射性药物与辐射防护

比活度对18F-rhPSMA-7.3生物分布的影响:临床PET数据回顾性分析

The Influence of Specific Activity on the Biodistribution of 18F-rhPSMA-7.3: A Retrospective Analysis of Clinical PET Data.
PubMed 文献 · J Nucl Med · 2021-08-12

本研究回顾性比较了高比活度(中位178.9 MBq/µg,n=42)与低比活度(中位19.3 MBq/µg,n=42)18F-rhPSMA-7.3 PET/CT在前列腺癌患者中的生物分布。低比活度组腮腺、颌下腺和脾脏的摄取中度但显著降低,其他正常器官和肿瘤病灶未见统计学显著差异。结论认为比活度降低约10倍对18F-rhPSMA-7.3生物分布影响轻微,支持18F标记PSMA配体可集中生产并配送至PET中心。

要点

  • 比活度降低约10倍仅使腮腺、颌下腺和脾脏摄取中度降低。
  • 其他正常器官和肿瘤病灶的摄取未见统计学显著差异。
  • 18F标记PSMA配体或可像18F-FDG一样集中生产并配送。

核心结论

  • 比活度降低约10倍对18F-rhPSMA-7.3的生物分布仅产生轻微影响。
  • 18F标记的PSMA配体可集中生产并配送至PET临床使用。

研究设计与样本

  • 回顾性分析临床PET数据,比较高比活度组(中位178.9 MBq/µg,n=42)与低比活度组(中位19.3 MBq/µg,n=42)前列腺癌患者的18F-rhPSMA-7.3 PET/CT生物分布。

主要发现

  • 低比活度组腮腺摄取中位SUVmean为16.7,高比活度组为19.2,差异显著。
  • 低比活度组颌下腺摄取中位SUVmean为18.1,高比活度组为22.3,差异显著。
  • 低比活度组脾脏摄取中位SUVmean为7.8,高比活度组为9.6,差异显著。
  • 其他正常器官和肿瘤病灶未见统计学显著差异。

临床怎么用

  • 18F-rhPSMA-7.3可集中生产并配送到PET中心,无需因比活度下降而调整临床流程。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We investigated whether the time between synthesis and injection and the resulting decrease in specific activity affects the normal-organ and tumor uptake of the PSMA ligand 18F-rhPSMA-7.3 in patients with prostate cancer. Methods: The biodistribution of 18F-rhPSMA-7.3 on PET/CT scans obtained with a high specific activity (median, 178.9 MBq/µg; n = 42) and a low specific activity (median, 19.3 MBq/µg; n = 42) was compared. Results: Tracer uptake by the parotid gland, submandibular gland, and spleen was moderately but significantly lower in the low-specific-activity group than in the high-specific-activity group (median SUVmean, 16.7 vs. 19.2; 18.1 vs. 22.3; and 7.8 vs. 9.6, respectively). No other statistically significant differences were found for normal organs or tumor lesions. Conclusion: A 10-fold decrease in specific activity has only minor effects on the biodistribution of 18F-rhPSMA-7.3. These findings suggest that 18F-labeled PSMA ligands can be centrally produced and shipped to PET clinics in a similar way to 18F-FDG.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Langbein T, Wurzer A, Gafita A, et al. The Influence of Specific Activity on the Biodistribution of 18F-rhPSMA-7.3: A Retrospective Analysis of Clinical PET Data. J Nucl Med. 2021. PMID: 34385338. doi:10.2967/jnumed.121.262471

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。